Phenotype standardization for drug-induced kidney disease

Area of Science:

• Nephrology and Pharmacology
• Adverse Drug Event Research

Background:

• Drug-induced kidney disease is a common cause of renal dysfunction lacking standardized diagnostic criteria.
• The International Serious Adverse Events Consortium initiated a project to standardize phenotypes for drug-induced kidney disease.

Framework:

• Proposed four phenotypes: acute kidney injury, glomerular, tubular, and nephrolithiasis.
• Defined primary/secondary clinical criteria and time courses based on KDIGO/AKIN standards.
• Acknowledged challenges in establishing causality, requiring biological plausibility, mechanism, and risk factor assessment.

Implementation:

• Convened an international panel of nephrologists and pharmacists.
• Developed standardized phenotypes for consistent evaluation of drug nephrotoxicity.

Implications:

• Provides a consistent framework for clinicians, researchers, industry, and regulatory agencies.
• Represents a crucial first step toward recognizing and managing drug-induced kidney disease.
• Aims to improve prevention and treatment strategies for drug nephrotoxicity.